Entry |
|
Symbol |
CCND1
|
Name |
|
KO |
K04503 | G1/S-specific cyclin-D1 |
|
Organism |
mdo Monodelphis domestica (gray short-tailed opossum)
|
Pathway |
mdo04919 | Thyroid hormone signaling pathway |
mdo04933 | AGE-RAGE signaling pathway in diabetic complications |
mdo05163 | Human cytomegalovirus infection |
mdo05166 | Human T-cell leukemia virus 1 infection |
mdo05167 | Kaposi sarcoma-associated herpesvirus infection |
mdo05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
KEGG Orthology (KO) [BR:mdo00001]
09130 Environmental Information Processing
09132 Signal transduction
04310 Wnt signaling pathway
100013257 (CCND1)
04340 Hedgehog signaling pathway
100013257 (CCND1)
04390 Hippo signaling pathway
100013257 (CCND1)
04371 Apelin signaling pathway
100013257 (CCND1)
04630 JAK-STAT signaling pathway
100013257 (CCND1)
04068 FoxO signaling pathway
100013257 (CCND1)
04151 PI3K-Akt signaling pathway
100013257 (CCND1)
04152 AMPK signaling pathway
100013257 (CCND1)
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
100013257 (CCND1)
04115 p53 signaling pathway
100013257 (CCND1)
04218 Cellular senescence
100013257 (CCND1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100013257 (CCND1)
04530 Tight junction
100013257 (CCND1)
09150 Organismal Systems
09152 Endocrine system
04917 Prolactin signaling pathway
100013257 (CCND1)
04921 Oxytocin signaling pathway
100013257 (CCND1)
04919 Thyroid hormone signaling pathway
100013257 (CCND1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100013257 (CCND1)
05206 MicroRNAs in cancer
100013257 (CCND1)
05205 Proteoglycans in cancer
100013257 (CCND1)
05207 Chemical carcinogenesis - receptor activation
100013257 (CCND1)
05203 Viral carcinogenesis
100013257 (CCND1)
09162 Cancer: specific types
05210 Colorectal cancer
100013257 (CCND1)
05212 Pancreatic cancer
100013257 (CCND1)
05225 Hepatocellular carcinoma
100013257 (CCND1)
05226 Gastric cancer
100013257 (CCND1)
05214 Glioma
100013257 (CCND1)
05216 Thyroid cancer
100013257 (CCND1)
05221 Acute myeloid leukemia
100013257 (CCND1)
05220 Chronic myeloid leukemia
100013257 (CCND1)
05218 Melanoma
100013257 (CCND1)
05219 Bladder cancer
100013257 (CCND1)
05215 Prostate cancer
100013257 (CCND1)
05213 Endometrial cancer
100013257 (CCND1)
05224 Breast cancer
100013257 (CCND1)
05222 Small cell lung cancer
100013257 (CCND1)
05223 Non-small cell lung cancer
100013257 (CCND1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100013257 (CCND1)
05160 Hepatitis C
100013257 (CCND1)
05162 Measles
100013257 (CCND1)
05163 Human cytomegalovirus infection
100013257 (CCND1)
05167 Kaposi sarcoma-associated herpesvirus infection
100013257 (CCND1)
05169 Epstein-Barr virus infection
100013257 (CCND1)
05165 Human papillomavirus infection
100013257 (CCND1)
09166 Cardiovascular disease
05416 Viral myocarditis
100013257 (CCND1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100013257 (CCND1)
04933 AGE-RAGE signaling pathway in diabetic complications
100013257 (CCND1)
04934 Cushing syndrome
100013257 (CCND1)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
100013257 (CCND1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
5:304444308..304455088
|
AA seq |
292 aa
MEHQLLCCEVETIRRAYLDANLLNDRALQTMLKAEETCSPSVSYFKCVQKDILPYMRKIV
ATWMLEVCEEXKCEREVFLSALNYSDRVLSLEPVKKSRLXVPGATCMFGGSRMKETLPPD
GRKLASSPHHPGPPQELSHMELLLVNKLKWHLAAMTPHDFIEHFLSKMPVLEENKQIIRK
HAQTFVALCATDVKFISNPPSMIAAGSVVAAVQGLHLGSTNSFLTYQRLTRFLSQVIKCD
PDCLRACQEQIEALLESSLRQAQQHSAAAAPKNVEEEGGLSYTPTDVRDVNI |
NT seq |
879 nt +upstreamnt +downstreamnt
atggagcaccagctgctgtgctgcgaggtggagaccatccgccgggcgtacctcgatgcc
aacctcctgaacgaccgagcgctgcagaccatgctcaaagccgaggagacatgctcgccc
tccgtgtcgtacttcaagtgcgtgcagaaggacatcctgccctacatgcgcaagatcgtg
gccacctggatgctcgaggtgtgcgaagagtagaaatgcgaaagagaagtcttcctctcg
gccctgaactattcggaccgggttctgtccctggagcccgtgaagaaaagccggctgtag
gtgccgggggccacttgcatgttcggggggtccagaatgaaggagactcttcctcctgac
ggccgaaaattggcatcttctcctcaccacccggggccgcctcaggagctctctcacatg
gagctgctcctggtgaacaagctgaagtggcacctcgccgccatgaccccccacgacttc
atcgaacactttctgtccaagatgccggtgctggaggagaacaagcagatcatccgcaag
cacgcgcagaccttcgtggccctctgcgccaccgacgtgaagttcatttccaacccccct
tccatgatcgccgcgggcagcgtggtcgccgccgtccagggcctgcacttggggagcacc
aactccttcctgacctaccagcgcctcacccgcttcctgtctcaagtcattaagtgtgac
ccggattgcttgcgagcctgccaggagcagatcgaagccctcctcgagtcgagcctgcgc
caggcccagcagcacagcgcggcggcggcgcccaagaacgtggaggaggagggaggcctg
tcctacacgcccaccgacgtgcgagacgtgaacatttga |